JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, M. A.

Development of a "blood-brain barrier" to methadone in the newborn rat

MA Peters

The chronic administration of dl-methadone to female rats during gestation results in the simultaneous administration of the drug to the unborn fetus. The tissue concentration of methadone in fetal brain is several-fold greater than in maternal brain. Methadone concentration in other maternal tissues studied was higher than in their fetal counterpart. Similar brain concentrations of methadone were seen in 19- to 21-day fetal rats, taken from mothers who had been treated with methadone, as was found in 1-day-old pups which were given an i.p. injection of methadone directly. The amount of methadone concentrating in the brain from a single 5 mg/kg dose increased with increasing postnatal age until about day 15 and then decreased to near adult levels by days 30 to 35. The blood concentration of methadone was more or less constant with all age groups and was significantly lower than brain concentrated at all time periods studied prior to day 30. The data presented would suggest that there is no true blood-brain barrier to methadone in either the young or the adult rat. However, there is some process which limits the brain content of methadone in the adult which is absent in the young animal. This process appears to be developed by about 30 to 35 days after birth. The apparent delay in the developmental processes seen in the pups born to and nursed by mothers chronically treated with methadone is not statistically significant.

Volume 192, Issue 3, pp. 513-520, 03/01/1975
Copyright © 1975 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics.